Delaware Bankruptcy Court

Case number: 1:23-bk-10112 - Acerus Biopharma Inc. and Acerus Pharmaceuticals Corporation - Delaware Bankruptcy Court

Case Information
Case title
Acerus Biopharma Inc. and Acerus Pharmaceuticals Corporation
Chapter
15
Judge
Mary F. Walrath
Filed
01/29/2023
Last Filing
08/31/2023
Asset
No
Vol
v
Docket Header

JNTADMN




U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 23-10112-MFW

Assigned to: Mary F. Walrath
Chapter 15
Voluntary


Date filed:  01/29/2023

Debtor

Acerus Biopharma Inc.

205-7025 Langer Drive
Mississauga
Ontario L5L 1J9
OUTSIDE U. S.
Canada
Tax ID / EIN: 00-0000000

represented by
Michael Jason Barrie

Benesch Friedlander Coplan & Aronoff LLP
1313 North Market Street
Suite 1201
Wilmington, DE 19801
(302) 442-7010
Fax : (302) 442-7012
Email: [email protected]

Jennifer R. Hoover

Benesch Friedlander Coplan & Aronoff LLP
1313 North Market Street
Suite 1201
Wilmington, DE 19801
302-442-7010
Fax : 302-442-7012
Email: [email protected]

Steven Walsh

Benesch Friedlander Coplan & Aronoff LLP
1313 North Market Street
Suite 1201
Wilmington, DE 19801
302-442-7059
Email: [email protected]

Foreign Representative

Acerus Pharmaceuticals Corporation

205-7025 Langer Drive
Mississauga
Ontario L5L 1J9
OUTSIDE U. S.
Canada
Tax ID / EIN: 98-1229465

represented by
Michael J. Barrie

Benesch, Friedlander, Coplan & Aronoff
1313 North Market Street
Suite 1201
Wilmington, DE 19801
302-442-7010
Fax : 302-442-7012
Email: [email protected]

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491
 
 

Latest Dockets
Date Filed#Docket Text
01/31/20234Docket Text
Order Directing Joint Administration of Chapter 15 Cases and Granting Related Relief. An order has been entered in this case directing the joint administration of the chapter 15 cases of Acerus Pharmaceuticals Corporation (6891); Acerus Biopharma Inc. (0687); Acerus Labs Inc. (0126); and Acerus Pharmaceuticals USA, LLC (9089). All further pleadings and papers shall be filed, and all further docket entries shall be made, in Case No. 23-10111 (MFW), and such docket should be consulted for all matters affecting these chapter 15 cases. (related document(s) 3). Signed on 1/31/2023. (LMC) (Entered: 01/31/2023)
01/30/2023Docket Text
Judge Mary F. Walrath added to case (SJS) (Entered: 01/30/2023)
01/29/20233Docket Text
Motion for Joint Administration Filed by Acerus Pharmaceuticals Corporation. (Hoover, Jennifer) (Entered: 01/29/2023)
01/29/2023Docket Text
Attorney Jennifer R. Hoover and Michael Jason Barrie for Acerus Biopharma Inc., Steven Walsh and Michael Jason Barrie for Acerus Biopharma Inc. added to case Filed by Acerus Biopharma Inc.. (Barrie, Michael) (Entered: 01/29/2023)
01/29/20232Docket Text
Receipt of filing fee for Petition Foreign Proceeding (Chapter 15)( 23-10112) [misc,volpfp15] (1738.00). Receipt Number A10977264, amount $1738.00. (U.S. Treasury) (Entered: 01/29/2023)
01/29/20231Docket Text
Chapter 15 Petition for Recognition of Foreign Proceeding. Fee Amount $1738 Filed by Acerus Biopharma Inc., Michael Jason Barrie. (Barrie, Michael) (Entered: 01/29/2023)